罗沙司他,CAS 登记号 808118-40-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 罗沙司他 的 CAS 号:808118-40-3,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Roxadustat · CAS 808118-40-3 · C19H16N2O5. UNII X3O30D9YMX. Solubility: <1 mg/mL.
| CAS Registry Number | 808118-40-3 |
|---|---|
| PubChem CID | 11256664 |
| Molecular formula | C19H16N2O5 |
| IUPAC name | 2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid |
| UNII (FDA) | X3O30D9YMX |
| Molecular Weight | 352.3 |
|---|---|
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 352.10592162 |
| Monoisotopic Mass | 352.10592162 |
| Topological Polar Surface Area | 109 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Solubility | <1 mg/mL |
|---|
| Reported hazard statements | H302 (66.7%), H315 (100%), H319 (100%), H332 (66.7%), H335 (100%) |
|---|
H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
Roxadustat; 808118-40-3; FG-4592; FG4592; Evrenzo; ASP 1517; ASP1517; ASP-1517; X3O30D9YMX; roxadustatum; FG 4592; (((4-Hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl)amino)acetic acid; CHEBI:132774; DTXSID60230644; N-[(4-hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl]glycine; [[(4-Hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl]amino]acetic Acid
CAS 808118-40-3; molecular formula C19H16N2O5; molecular weight — g/mol.
Roxadustat, 808118-40-3, FG-4592, FG4592, Evrenzo, ASP 1517.
Hazard statements reported: H302, H315, H319, H332, H335.
Solubility: <1 mg/mL.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.